Imaging of acute heart-transplant rejection using 99m-Technetium labelled oligonucleotides against interleukin-2 mRNA in rats

European Journal of Cardio-thoracic Surgery

Volumn 37, Issue 5, 2010, Pages 1111-1116

  Gierthmuehlen, Mortimer ^a,b   Sommer, Per ^b,c   Zuhayra, Maaz ^b   Hedderich, Juergen ^b   Jaenig, Ute ^b   Faendrich, Fred ^b   Henze, Eberhard ^b   Kampen, Willm Uwe ^b,d  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d Nuclear Medicine Spitalerhof   (Germany)

Author keywords

Anti sense; Cardiac; Graft; Oligonucleotide; Rejection; Transplantation

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; INTERLEUKIN 2; MESSENGER RNA; TACROLIMUS; TECHNETIUM 99M;

ACUTE GRAFT REJECTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CARDIAC GRAFT REJECTION; CONTROLLED STUDY; FEMALE; HEART SCINTISCANNING; HISTOPATHOLOGY; IMAGE ANALYSIS; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOACTIVITY; RAT;

ACUTE DISEASE; ANIMALS; BIOLOGICAL MARKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE MODELS, ANIMAL; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; INTERLEUKIN-2; MALE; OLIGONUCLEOTIDES, ANTISENSE; RADIOMETRY; RATS; RATS, INBRED LEW; RNA, MESSENGER; TECHNETIUM;

EID: 77951296036     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2009.12.014     Document Type: Article

References (28)

1. Sherman-Weber S., Axelrod P., Suh B., Rubin S., Beltramo D., Manacchio J., Furukawa S., Weber T., Eisen H., and Samuel R. Infective endocarditis following orthotopic heart transplantation: 10 cases and a review of the literature. Transpl Infect Dis 6 (2004) 165-170
2. Patel J.K., and Kobashigawa J.A. Should we be doing routine biopsy after heart transplantation in a new era of anti-rejection?. Curr Opin Cardiol 21 (2006) 127-131
3. Mills R.M., Naftel D.C., Kirklin J.K., Van Bakel A.B., Jaski B.E., Massin E.K., Eisen H.J., Lee F.A., Fishbein D.P., and Bourge R.C. Heart transplant rejection with hemodynamic compromise: a multi-institutional study of the role of endomyocardial cellular infiltrate Cardiac Transplant Research Database. J Heart Lung Transplant 16 (1997) 813-821
4. Suzuki J., Isobe M., Yamazaki S., Horie S., Okubo Y., and Sekiguchi M. Sensitive diagnosis of cardiac allograft rejection by detection of cytokine transcription in situ. Cardiovasc Res 40 (1998) 307-313
5. Mathier M.A., and McNamara D.M. Management of the patient after heart transplant. Curr Treat Options Cardiovasc Med 6 (2004) 459-469
6. Hnatowich D.J., Winnard Jr. P., Virzi F., Fogarasi M., Sano T., Smith C.L., Cantor C.R., and Rusckowski M. Technetium-99m labeling of DNA oligonucleotides. J Nucl Med 36 (1995) 2306-2314
7. Ono K., and Lindsey E.S. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 57 (1969) 225-229
8. Berry G.J., Brunt E.M., Chamberlain D., Hruban R.H., Sibley R.K., Stewart S., and Tazelaar H.D. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Lung Rejection Study Group. The International Society for Heart Transplantation. J Heart Transplant 9 (1990) 593-601
9. Stewart S., Winters G.L., Fishbein M.C., Tazelaar H.D., Kobashigawa J., Abrams J., Andersen C.B., Angelini A., Berry G.J., Burke M.M., Demetris A.J., Hammond E., Itescu S., Marboe C.C., McManus B., Reed E.F., Reinsmoen N.L., Rodriguez E.R., Rose A.G., Rose M., Suciu-Focia N., Zeevi A., and Billingham M.E. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 24 (2005) 1710-1720
10. Sakakibara S., and Konno S. Endomyocardial biopsy. Jpn Heart J 3 (1962) 537-543
11. Duquesnoy R.J., and Cramer D.V. Immunologic mechanisms of cardiac transplant rejection. Cardiovasc Clin 20 (1990) 87-103
12. Eckart R.E., Kolasa M.W., Khan N.A., Kwan M.D., and Peele M.E. Surface electrocardiography and histologic rejection following orthotopic heart transplantation. Ann Noninvasive Electrocardiol 10 (2005) 60-64
13. Kown M.H., Strauss H.W., Blankenberg F.G., Berry G.J., Stafford-Cecil S., Tait J.F., Goris M.L., and Robbins R.C. In vivo imaging of acute cardiac rejection in human patients using (99m)technetium labeled annexin V. Am J Transplant 1 (2001) 270-277
14. Aparici C.M., Narula J., Puig M., Camprecios M., Martin J.C., Tembl A., Flotats A., Estorch M., Catafau A.M., Berna L., Ballester M., and Carrio I. Somatostatin receptor scintigraphy predicts impending cardiac allograft rejection before endomyocardial biopsy. Eur J Nucl Med 27 (2000) 1754-1759
15. Isobe M., Narula J., Southern J.F., Strauss H.W., Khaw B.A., and Haber E. Imaging the rejecting heart In vivo detection of major histocompatibility complex class II antigen induction. Circulation 85 (1992) 738-746
16. Hoff S.J., Stewart J.R., Frist W.H., Atkinson J.B., Kronenberg M.W., Votaw J., Kessler R.M., and Sandler M.P. Noninvasive detection of acute rejection in a new experimental model of heart transplantation. Ann Thorac Surg 56 (1993) 1074-1077
17. Deng M.C., Erren M., Kammerling L., Gunther F., Kerber S., Fahrenkamp A., Assmann G., Breithardt G., and Scheld H.H. The relation of interleukin-6, tumor necrosis factor-alpha, IL-2, and IL-2 receptor levels to cellular rejection, allograft dysfunction, and clinical events early after cardiac transplantation. Transplantation 60 (1995) 1118-1124
18. Deng M.C., Erren M., Roeder N., Dreimann V., Gunther F., Kerber S., Baba H.A., Schmidt C., Breithardt G., and Scheld H.H. T-cell and monocyte subsets, inflammatory molecules, rejection, and hemodynamics early after cardiac transplantation. Transplantation 65 (1998) 1255-1261
19. George J.F., Kirklin J.K., Naftel D.C., Bourge R.C., White-Williams C., McGiffin D.C., Savunen T., and Everson M.P. Serial measurements of interleukin-6, interleukin-8, tumor necrosis factor-alpha, and soluble vascular cell adhesion molecule-1 in the peripheral blood plasma of human cardiac allograft recipients. J Heart Lung Transplant 16 (1997) 1046-1053
20. Mehra M.R., Uber P.A., Uber W.E., Park M.H., and Scott R.L. Anything but a biopsy: noninvasive monitoring for cardiac allograft rejection. Curr Opin Cardiol 17 (2002) 131-136
21. Hildebrandt M., and Reske S.N. Prerequisites for diagnostic use of antisense oligonucleotides in nuclear medicine. Nuklearmedizin 35 (1996) 126-131
22. Dewanjee M.K., Ghafouripour A.K., Kapadvanjwala M., Dewanjee S., Serafini A.N., Lopez D.M., and Sfakianakis G.N. Noninvasive imaging of c-myc oncogene messenger RNA with indium-111-antisense probes in a mammary tumor-bearing mouse model. J Nucl Med 35 (1994) 1054-1063
23. Stepkowski S.M. Development of antisense oligodeoxynucleotides for transplantation. Curr Opin Mol Ther 2 (2000) 304-317
24. Perry C.M., and Balfour J.A. Fomivirsen. Drugs 57 (1999) 375-380 [discussion 381]
25. Qu X., Kirken R.A., Tian L., Wang M., Bennett C.F., and Stepkowski S.M. Selective inhibition of IL-2 gene expression by IL-2 antisense oligonucleotides blocks heart allograft rejection. Transplantation 72 (2001) 915-923
26. Hnatowich D.J. Antisense and nuclear medicine. J Nucl Med 40 (1999) 693-703
27. Zhang Y.M., Wang Y., Liu N., Zhu Z.H., Rusckowski M., and Hnatowich D.J. In vitro investigations of tumor targeting with (99m)Tc-labeled antisense DNA. J Nucl Med 42 (2001) 1660-1669
28. Kurreck J. Antisense technologies. Improvement through novel chemical modifications. Eur J Biochem 270 (2003) 1628-1644